NovAccess Global Inc. (OTCMKTS:XSNX) Brief Interest Update
NovAccess Global Inc. (OTCMKTS: XSNX – Get a rating) was the target of a sharp drop in short interest during the month of March. As of March 31, there was selling interest totaling 4,600 shares, down 25.8% from the March 15 total of 6,200 shares. Based on an average daily volume of 2,500 shares, the short interest ratio is currently 1.8 days.
XSNX opened at $0.43 on Friday. The company has a 50-day simple moving average of $0.41 and a two-hundred-day simple moving average of $0.43. NovAccess Global has a 52 week minimum of $0.25 and a 52 week maximum of $0.97.
About NovAccess Global (Get a rating)
NovAccess Global Inc, a biopharmaceutical company, is developing novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to using a patient’s immune system to attack cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.
Get news and reviews for NovAccess Global Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for NovAccess Global and related companies with MarketBeat.com’s FREE daily newsletter.